↓ Skip to main content

The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro

Overview of attention for article published in Antiviral Research, June 2020
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#1 of 2,304)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Citations

dimensions_citation
941 Dimensions

Readers on

mendeley
2731 Mendeley
Title
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
Published in
Antiviral Research, June 2020
DOI 10.1016/j.antiviral.2020.104787
Pubmed ID
Authors

Leon Caly, Julian D. Druce, Mike G. Catton, David A. Jans, Kylie M. Wagstaff

Twitter Demographics

The data shown below were collected from the profiles of 23,895 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 2,731 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 2731 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 390 14%
Researcher 318 12%
Student > Master 288 11%
Student > Ph. D. Student 236 9%
Other 177 6%
Other 647 24%
Unknown 675 25%
Readers by discipline Count As %
Medicine and Dentistry 557 20%
Biochemistry, Genetics and Molecular Biology 279 10%
Pharmacology, Toxicology and Pharmaceutical Science 252 9%
Agricultural and Biological Sciences 161 6%
Chemistry 128 5%
Other 536 20%
Unknown 818 30%

Attention Score in Context

This research output has an Altmetric Attention Score of 21208. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 October 2021.
All research outputs
#18
of 19,151,080 outputs
Outputs from Antiviral Research
#1
of 2,304 outputs
Outputs of similar age
#6
of 286,224 outputs
Outputs of similar age from Antiviral Research
#1
of 21 outputs
Altmetric has tracked 19,151,080 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,304 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 18.6. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 286,224 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 21 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.